Breast cancer cells with higher RUNX2 expression have a stronger ability to migrate, partly due to the upregulation of EMT-related genes such as MMP2, MMP9, MMP13, BSP, etc. [15]. This evidence concerns the gene RUNX2 and breast carcinoma.